FDA: Singulair to Get ' Black Box ' Warning

THURSDAY, March 5, 2020 -- Asthma and allergy drug montelukast -- sold as a generic and under the brand name Singulair -- will get a " boxed warning " over potential ties to neuropsychiatric effects, the U.S. Food and Drug Administration announced...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news